Background-Computed tomographic coronary angiography (CTA), given its high negative predictive value, is a potential gatekeeper for invasive coronary angiography (ICA). Before CTA can be further accepted into clinical practice, its impact on healthcare resources needs to be better understood. We sought to determine the clinical impact of CTA on ICA referrals, CTA accuracy, and normalcy rate. Methods and Results-To determine the impact of CTA, consecutive patients (nϭ7017) undergoing ICA before and after implementing a dedicated cardiac CT program were reviewed and compared with 3 other centers (nϭ11 508). To determine CTA accuracy, we evaluated consecutive CTA patients who underwent ICA. For normalcy rate, we identified patients with a low pretest probability for obstructive coronary artery disease. With the implementation of a cardiac CT program, the frequency of normal ICA decreased from 31.5% (1114 of 3538 patients) to 26.8% (932 of 3479 patients) (PϽ0.001). These findings were significantly different (Pϭ0.003) from the 3 centers, in which normal ICAs were unchanged (30.0% [1870 of 6224 patients] to 31.0% [1642 of 5284 patients]). CTA had excellent per-patient sensitivity (99% [CI, 95% to 100%]), positive predictive value (92% [CI, 86% to 96%]) and negative predictive value (95% [CI, 72% to 100%]). Because of referral bias, specificity (64% [CI, 44%
Single center studies have compared the accuracy of CTA to invasive coronary angiography (ICA) and have reported very good sensitivity and negative predictive value. 8 -10 CTA may be an effective gatekeeper to ICA by identifying patients without significant coronary stenoses thus eliminating their need for ICA and reserving ICA for those patients who may benefit most from coronary revascularization. The clinical impact of CTA on healthcare resource utilization and health economics has not been well studied. Because cardiac CT and cardiac catheterization services are centralized to a single tertiary-care center (University of Ottawa Heart Institute [UOHI]) servicing a population of 1.5 to 1.8 million, our center is in a unique position to accurately assess the direct clinical impact of cardiac CT. We sought to understand the potential impact of CTA on referrals to ICA.
As CTA becomes accepted clinically, it is anticipated that future accuracy studies will demonstrate a decline in specificity and rise in sensitivity, as observed with other imaging modalities. 11 Future analyses demonstrating declines in specificity will be attributed to verification and referral bias resulting from ICA performed primarily in patients with abnormal CTA findings. 12 To account for such bias, the concept of normalcy rate (NR) has been developed and is defined as the frequency of normal studies in a population with a low pretest probability for CAD. 11 Such NRs provide a more accurate estimate of the true specificity of a diagnostic test in clinical practice. 11 As CTA is accepted into clinical practice, studies defining the accuracy and NR of CTA are needed to understand their potential impact in real-life clinical practice. We sought to assess the diagnostic characteristics and NR of CTA in real-life clinical practice.
The objectives of this study were to (1) understand the clinical impact of CTA on referrals to ICA and (2) determine the accuracy and NR of CTA.
Methods
We evaluated the following 3 cohorts: 1. To understand the impact of CTA on ICA, all left heart catheterizations beginning January 1, 2005, were retrospectively screened. Screening of left heart catheterizations was continued for 13 months after the implementation of the CTA program. 2. To ensure that the results at the UOHI were related to establishment of cardiac CT and not because of the changes in ICA referral patterns, ICA patterns (using the same time periods) at 3 academic tertiary-care Canadian institutions (without a dedicated cardiac CT program) were screened using the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) database. To ensure that there was no overlap of patients, the 3 chosen institutions were in different provinces and were more than 1000 km away from the UOHI. 3. To assess CTA accuracy, all clinical CTA studies were prospectively screened and NR was calculated using all patients prospectively enrolled in a cardiac CT registry. Indications for CTA included chest pain, dyspnea, equivocal stress test result, or heart failure. (Figure 1 ).
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Diagnostic ICA
All ICA reports were reviewed at the UOHI. When reports were inadequate, an observer blinded to the clinical data reviewed the ICA images. Results were categorized as normal if there was no significant obstructive CAD (diameter stenosis Ͻ50%) or abnormal if there was Ն1 coronary segment with diameter stenosis Ն50%. 13, 14 The same criteria were used to query the APPROACH database. Retrospective ECG-gated data sets were acquired with the GE Volume CT (GE Healthcare) with 64ϫ0.625 mm slice collimation and a gantry rotation of 350 msec (mAϭ300 to 800, kVϭ120). Pitch (0.16 to 0.24) was individualized to the patient's heart rate. The CT data sets were reconstructed with an increment of 0.4 mm using the cardiac phase with the least cardiac motion.
Computed Tomographic Coronary Angiography
CTA Image Analysis
Images were processed using the GE Advantage Volume Share Workstation (GE Healthcare) and visually interpreted by 1 of 2 
CTA Accuracy
Of the 1029 consecutive cardiac CT patients, those without a history of revascularization, who underwent ICA were analyzed. The diagnostic characteristics of CTA (sensitivity, specificity, negative predictive value, and positive predictive value were calculated on a per-patient basis. 8, 15, 16 
NR Population
Between February 2006 and September 2007, consecutive patients with a low pretest probability (Յ5.5%) for obstructive CAD, imaging heart rate Յ70 and BMI Յ40 kg/m 2 were identified. Patient pretest probability for obstructive CAD was calculated using age, gender, and symptoms. 13, 14, 17 Two patients were excluded because of repaired anomalous origin of the left coronary artery from the pulmonary artery.
Measurement of NR
Normal was defined as the absence of obstructive CAD, 11, 13, 14 and NRs were calculated using 2 definitions for obstructive CAD (Ն50% and Ն70% coronary artery diameter stenosis), as defined by Diamond-Forrester and the CASS Registry. 13, 14 The study was approved by the institutional human research ethics board. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Statistical Analysis
Statistical analyses were performed (G.W. and L.C.) using SAS (version 9.1.3, SAS Institute Inc, Cary, NC), and statistical significance was defined as PϽ0.05. Continuous variables are presented as means and standard deviations, and categorical variables are presented as frequencies with percentages. The Wilcoxon rank sum test was used to compare continuous variables, and Fisher exact test was used for categorical variables.
Impact of CTA on ICA Referrals
To assess the impact of CTA on ICA referrals, an autoregressive integrated moving-average model with binary intervention term (0, ϽMarch 2006 and 1, ՆMarch 2006) was used to compare the monthly frequency of normal ICA before and after the establishment of a dedicated cardiac CT in the time series of January 1, 2005, to February 28, 2007. The seasonal pattern was also considered in the autoregressive integrated moving-average model. The change of the frequency of normal ICA was compared between our institution and the controls at 3 APPROACH institutions using the ANOVA.
CTA Accuracy
Diagnostic test characteristics (sensitivity, specificity, negative predictive value, and positive predictive value) are reported with 95% CIs. Positive and negative likelihood ratios were weighted for the prevalence of CAD in the study cohort. Adjusted sensitivity, specificity, negative predictive value, and positive predictive value were generated to correct for referral bias using the Diamond 18 method and 95% CI for the adjusted estimates were obtained using bootstrap approach.
Results
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Over a 26-month period, a total 7017 patients had elective diagnostic ICA. Data were collected for 13 months after the implementation of cardiac CT. At the time of CT implementation, the waiting time for elective coronary angiography was 1 month. As such, it was estimated that any impact of CTA would become evident after 1 month. Thus, the patient population was divided into the 14 months before the effects of CTA (3538 patients) and the 12 months after the effects of CTA (3479 patients) ( Figure 1) . The impact assessment model showed that there was a reduction in the frequency of normal angiograms (31.5% versus 26.8%; PϽ0.001) at the UOHI with the implementation of cardiac CT (Figure 2A) . Similarly, there was a reduction in the frequency of normal angiograms performed in elective patients without prior revascularization (39.4% versus 34.7%; Pϭ0.006) ( Figure 2B ). Comparing the 2 populations (before versus after CT), ICA patients after CTA implementation were older and had a greater frequency of cardiac risk factors (Table 1) .
During the exact same time period, a total of 11 508 patients underwent elective ICA at 3 APPROACH institutions ( 
CTA Accuracy
A total of 1029 patients who underwent clinically indicated cardiac CT. Of these, 482 (46.8%) patients had stress tests performed within the preceding 3 months. CTA was requested to rule out CAD in 705 patients and/or to clarify equivocal stress test results in 251 patients.
A total of 543 (52.8%) CTAs were normal (no significant coronary stenoses), 37.7% were abnormal (Ն1 coronary stenoses [Ն50%]), and 9.5% had incomplete CTA evaluation or were nondiagnostic (Ն1 nonevaluable coronary segment in the absence of coronary stenoses in evaluable segments). A total of 148 patients underwent both CTA and clinically indicated ICA. The prevalence of obstructive CAD was 81%. CTA had excellent per-patient sensitivity (99% [CI, 95% to 100%]), positive predictive value (92% [CI, 86% to 96%]) and negative predictive value (95% [CI, 72% to 100%]) for CAD (Tables 3 and 4 ). As expected, the specificity was lower (64% [CI, 44% to 81%]). The positive likelihood and negative likelihood ratios (weighted for prevalence) were 11.9 (CI, 6.5 to 21.6) and 0.06 (CI, 0.01 to 0.38), respectively. After adjusting for referral bias, the adjusted sensitivity was 90% (CI, 89% to 91%), the adjusted specificity was 95% (CI, 94% to 96%) with positive and negative predictive values of 92% (CI, 91% to 93%) and 93% (CI, 92% to 94%), respectively.
NR
Of the 210 patients in the normalcy study, 9 (4.3%) were excluded from analysis for Ն1 unevaluable coronary segment because of patient motion (1 patient), premature ventricular complexes (2 patients), and cardiac motion (6 patients). Of the remaining 201 patients, 68 (34%) patients had evidence of coronary atherosclerosis with 10 patients having moderate stenoses and 3 with severe stenoses ( Table 5 ). Using thresh-olds of Ն50% and Ն70% stenoses, the NR of CTA was 94% (CI, 90% to 97%) and 99% (CI, 96% to 100%), respectively. Two patients with severe stenoses had their CTA findings confirmed by ICA and were revascularized. The third patient, with a severe stenosis in a diagonal branch, had a corresponding myocardial perfusion defect.
Discussion
Impact of CTA on Referrals to ICA
Cardiac CTA has a very high negative predictive value and thus may be effective in ruling out obstructive CAD. [1] [2] [3] [4] [5] [6] 9 The high negative predictive value and NR in our study supports this previously reported diagnostic characteristics 1-6,9 and may account for the reduction of normal ICA observed following the implementation of cardiac CT. The ability of CTA to rule out disease is extremely desirable, enabling clinicians to restrict the use of ICA to patients requiring revascularization. Because cardiac CT and cardiac catheterization services are centralized to a single tertiary care center servicing a population of 1.5 to 1.8 million, our center is in a unique position to accurately assess the direct clinical impact of cardiac CT.
These observations are further supported by the fact that our cardiac CT program had restricted access and is primarily limited to cardiologists, internists, and cardiac surgeons who refer patients to ICA. To ensure that our observations were unique to our institution, normal angiogram rates were assessed at 3 academic tertiary-care Canadian institutions without dedicated cardiac CT programs. These institutions demonstrated that the frequency of normal angiograms were unchanged during the same time periods.
To further ensure that our control population was not biased by regional practices, 3 other institutions from a different province were queried using the APPROACH database. Because of unavailable patient baseline characteristics, these data were not included in our primary analysis. However, these 3 centers reported an increase in normal angiograms from 27.8% (1290 of 4640) to 30.2% (1234 of 4088) during the same time periods.
We also observed that following the implementation of cardiac CT program, patients who subsequently were referred to ICA had greater risk factors. One may speculate that once CTA has been implemented, lower risk individuals would be excluded from ICA and thus explaining the apparent rise in cardiac risk factors.
Thus CTA is available as an alternative to ICA and its use may have facilitated better patient selection for ICA. Whether or not such patient selection improves overall population outcomes warrants further evaluation.
Accuracy of CTA
The results of this study confirm that CTA, when accepted in to clinical practice has high sensitivity, negative predictive value, and positive predictive value. Additionally, when weighted for the CAD prevalence in our study cohort, the high positive likelihood ratio and low negative likelihood ratio, suggest that CTA may be an effective diagnostic test. As expected due to referral and verification bias, the specificity of CTA fell to 64%; however, the adjusted specificity was 95%. To address this fall in specificity, the NR was also calculated.
NR
Single center studies have demonstrated that CTA has excellent operating characteristics for the identification of patients with significant CAD. However, these accuracy studies are subject to referral bias because the study patients had clinical indications for ICA. CTA has been quickly adopted into clinical practice and it is anticipated that future accuracy studies may demonstrate a decline in specificity. 11 Such changes in specificity are attributed to verification and referral bias because ICA would typically be performed in patients with abnormal CTA and uncommonly in patients with nonobstructive CAD or normal CTA. 12 To account for such bias, the notion of NR has been developed.
The NR of other noninvasive imaging modalities has been reported. The majority of these studies used single photon emission computed tomography and demonstrated a mean NR of 91%. 11,19 -23 Bach et al showed that the NR of dobutamine stress echocardiography was 94% in patients with a pretest probability Յ5% and 92% in patients with a pretest probability Յ10%. 24 Sampson et al determined that the NR of positron-emission tomography/CT in 64 patients was 100%. 25 Our study demonstrates that CTA has a very good NR and is similar to other noninvasive imaging modalities.
Though it is desirable to attain high NR, the NR should not be 100%. By screening large populations with a pretest probability Ͼ0% for obstructive CAD, one would expect to diagnose patients with CAD. Because our study population had a mean pretest probability of 3.1%, it was not unexpected to have made the diagnosis of obstructive CAD in some patients.
Role of CTA in the Diagnostic Pathway for Patients With Suspected CAD
The role of CTA in the diagnostic algorithm has yet to be determined; however, the diagnostic characteristics and NR are encouraging. Given the high sensitivity, negative predictive value, and NR of CTA, one may speculate that CTA is useful in ruling out CAD. Such benefit would be further supported if there was also a cost-benefit associated with CTA. Though a cost-analysis was beyond the scope of this study and requires further study, preliminary analysis at our institution suggests that 1029 CTAs may have eliminated the need for ICA in 164 patients and may have resulted in a cost-saving.
Limitations
Examining the impact of CTA at a single center could result in an overestimation of its beneficial effects, especially if CTA had a negative impact on other catheterization laboratories which was not accounted for. Though a potential limitation at other centers, coronary catheterization services are centralized to our institution which serves a population of 1.5 to 1.8 million. The negative effects of cardiac CT on distant catheterization laboratories are not an issue. Similarly, as the only cardiac CT program for the same population, the impact of CT is directly attributable to the local cardiac CT program.
We observed some variability in the baseline characteristics between the UOHI and the 3 control centers but attribute them to possible differences in the definitions used to identify risk factors. Because the population across Canada is relatively homogeneous, one would have expected similar changes in baseline characteristics across all sites. The increased prevalence of cardiac risk factors at the UOHI after the implementation of CT, suggests that a lower risk population was appropriately screened and the need for ICA eliminated.
It is well accepted that the NPV of CTA is very high and we would anticipate that a similar effect would be expected at other centers. However, we recognize that interobserver variability and patient referral patterns may limit these effects.
Our study did not evaluate upstream or downstream utilization of other noninvasive modalities after CTA nor did we compare CTA to other noninvasive methods. Other ongoing studies such as study of Perfusion Versus Anatomy's Role in CAD (SPARC) are considering these questions. 26 However, these studies will not compare cohorts before and after the availability of CTA as has been done in the current study.
Our CTA accuracy data are limited by referral and verification bias and therefore we reported the NR of CTA which is believed to be an indirect measure of specificity after a test has been adopted into clinical practice. Though some have advocated the use of normal volunteers to determine NR, the radiation exposure associated with CTA does not permit the screening of normal volunteers. The American College of Cardiology Practice Guidelines for Radionuclide Imaging has indicated that patients with a low pretest probability should be preferentially chosen because they reflect the clinical population. 11
Conclusions
The implementation of a cardiac CT program reduced the rate of normal angiography compared with controls in this study population. The ability of CTA to rule out disease may have a positive impact on clinical practice, specifically the patient selection for ICA, and may be accompanied by a potential cost savings. Further studies examining the cost-effectiveness of cardiac CT are required. The diagnostic characteristics and NR of CTA suggest that it may be a clinically useful diagnostic tool. Data are presented as meanϮSD or n (%). LV indicates left ventricular; CP, chest pain.
